Infectious Keratitis Clinical Trial
Official title:
Use of a New Rapid Multiplex PCR System for the Microbiological Diagnosis of Severe Infectious Keratitis: Impact on Therapeutic Management (ABCORFILM Study)
Microbial keratitis is a severe and often blindness-inducing pathology which represents today the first reason for long-term hospitalization (more than 5 days) in ophthalmology. Its diagnosis is clinical and leads to an immediate hospitalization in the presence of serious criteria (Mackie classification). The entire process of microbiological diagnosis requires several days before etiological confirmation and therefore delays the initiation of targeted therapy. Recently, new PCR systems allowing the detection of 18 to 27 pathogens in 75 minutes have been developed. Their use could thus be transposed to ophthalmology by adapting the microbiological diagnostic technique to samples currently taken by swabbing the cornea. The investigators will compare their diagnosis performance versus conventional methods on patients who suffered for a microbial keratitis with severity criteria.
46 patients enrolled for severe infectious keratitis will be recruited in the department of Ophthalmology, Robert Debré Hospital, Reims, France. The study will be composed by 2 groups. The first, also called "before group" will contain 23 patients who were anteriorly hospitalized for a severe infectious keratitis in our hospital unit. They received standard microbiological diagnosis methods: Direct microscopic examination with Gram stain, bacterial and fungal cultures, viral and amoebic polymerase chain reaction [PCR]). The second, also called "after group" will enroll patients who suffer for a severe infectious keratitis (prospective group). Each patient will benefit a complete ophthalmologic examination, corneal scrapping and swabbing for standard microbiological diagnosis methods along with another corneal swabbing sample for the use of two different FilmArray® PCR systems identified as "ME" for Meningitis-Encephalitis and "BCID" for Blood Culture Identification. The investigators hypothesize that the use of rapid multiplex PCR tests for the microbiological diagnosis of severe corneal infections could in the future prove to be more efficient than the current diagnostic strategy, on the one hand, by shortening the time to identify the pathogen and therefore to implement a targeted treatment, and on the other hand, by systematically searching for a large number of pathogens well beyond those targeted today. In addition, the benefits of this technique applied to ophthalmology could improve the long-term visual prognosis, reduce the length of hospitalization and therefore the diagnostic and management costs of these patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04030403 -
Investigation of the Microbiome of the Cornea in Microbial Keratitis
|
||
Completed |
NCT04213313 -
Association Between SNP of SP-D and Susceptibility and Prognosis of Infectious Keratitis
|
||
Recruiting |
NCT02570321 -
Cross-linking for Corneal Ulcers Treatment Trial
|
Phase 4 | |
Terminated |
NCT00912509 -
Cross Linking for Treatment of Corneal Infection
|
N/A | |
Completed |
NCT01831206 -
Collagen Cross-linking in Infectious Keratitis Trial
|
Phase 2 | |
Completed |
NCT04383431 -
Cross-linking as Treatment in Infectious Keratitis
|
N/A | |
Not yet recruiting |
NCT03801590 -
Crosslinking in Infectious Keratitis
|
N/A | |
Recruiting |
NCT06364878 -
Non-invasive Diagnostics of Microbial Keratitis
|
||
Completed |
NCT01739673 -
Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
|
N/A | |
Completed |
NCT02819232 -
Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs
|
N/A |